City

Assiut (1)

Gentofte (1)

Mexico City (1)

Shanghai (1)

Condition

Type 2 Diabetes With Renal Manifestations (4)

Type 2 Diabetes (1)

Overall Status

Recruiting (2)

Active, not recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 4 (1)

Sponsor

Assiut University (1)

Hospital Juarez de Mexico (1)

Shanghai East Hospital (1)

Steno Diabetes Center Copenhagen (1)

Collaborator

Chinese PLA General Hospital (1)

Novo Nordisk A/S (1)

Intervention

empagliflozin 25 mg (1)

human umbilical cord mesenchymal stem cells (1)

placebo, 1,34 mg/ml (1)

saline (1)

semaglutide, 1.34 mg/ml (1)

Study Documents

Intervention Type

other (2)

biological (1)

drug (1)

Funder Type

Other (4)

Study Type

Interventional (2)

Observational (2)

type 2 diabetes with renal manifestations

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Chronic Kidney Disease Among Type 2 Diabetic Assiut University

Recruiting

Type 2 Diabetes With Renal Manifestations

Assiut, Egypt

Assiut

May 5, 2023

Through Transcriptomics

Active, not recruiting

Type 2 Diabetes
Type 2 Diabetes With Renal Manifestations

Mexico City, Mexico

Hospital Juárez de México

May 12, 2022

Type 2 Diabetes With Renal Manifestations Trial in Shanghai (human umbilical cord mesenchymal stem cells, saline)

Recruiting

Type 2 Diabetes With Renal Manifestations

human umbilical cord mesenchymal stem cells
saline

Shanghai, Shanghai, China

Shanghai East Hospital

Dec 16, 2020

Type 2 Diabetes With Renal Manifestations Trial in Gentofte (Semaglutide, 1.34 mg/mL, Placebo, 1,34 mg/mL, Empagliflozin 25 MG)

Unknown status

Type 2 Diabetes With Renal Manifestations

Semaglutide, 1.34 mg/mL
+2 more

Gentofte, Denmark

Steno Diabetes Center Copenhagen

Aug 16, 2019